Application of biomaterials in cardiac tissue engineering: Current status and prospects

Abstract

Cardiovascular diseases have become one of the leading causes of death and illness worldwide, posing significant challenges to global health. Due to the limited regenerative capacity of the heart, conventional approaches to treating heart diseases have demonstrated limited effectiveness. Therefore, leveraging biomaterials and biotechnologies in cardiac tissue engineering has emerged as a promising therapeutic strategy. This review aims to summarize the various characteristics of biomaterials in cardiac tissue engineering and their significance in addressing heart diseases. We categorize biomaterials into natural, synthetic, and conductive types based on their sources and unique properties, focusing on their applications in cardiac tissue engineering. We then present current applications of biomaterials in cardiac tissue engineering, followed by a discussion of existing challenges such as long-term material stability, biocompatibility, adverse reactions, and precise application methodologies. Additionally, we provide insights into potential strategies for overcoming these challenges, aiming to enhance the effectiveness and safety of biomaterials in cardiac tissue engineering applications. Finally, this review highlights the potential of emerging biomaterials and technologies, underscoring the critical role of interdisciplinary collaboration in driving innovation and progress in cardiac tissue engineering.

Keywords

biocompatibility / biomaterials / cardiac tissue engineering / electroactive

References

[1] OrganizationWH. World health statistics 2024: monitoring health for the SDGs sustainable development goals. 2024.

[2] (IHME) IfHMaE. Global Burden of Disease 2021: Findings from the GBD 2021 Study. 2024.

[3] TsaoCW, AdayAW, AlmarzooqZI, et al. Heart disease and stroke Statistics-2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93-e621.

[4] HashimotoH, OlsonEN, Bassel-DubyR. Therapeutic approaches for cardiac regeneration and repair. Nat Rev Cardiol. 2018;15(10):585-600.

[5] IzadifarM, KellyME, ChenX. Engineering angiogenesis for myocardial infarction repair: recent developments, challenges, and future directions. Cardiovasc Eng Technol. 2014;5(4):281-307.

[6] DunnDA, HodgeAJ, LipkeEA. Biomimetic materials design for cardiac tissue regeneration. WIREs Nanomed Nanobiotechnol. 2014;6(1):15-39.

[7] HeL, ChenX. Cardiomyocyte induction and regeneration for myocardial infarction treatment: cell sources and administration strategies. Adv Healthcare Mater. 2020;9(22):e2001175.

[8] RajabTK, Jaggers J, CampbellDN. Heart transplantation following donation after cardiac death: history, current techniques, and future. J Thorac Cardiovasc Surg. 2021;161(4):1335-1340.

[9] KounatidisD, BrozouV, AnagnostopoulosD, PantosC, Lourbopoulos A, MourouzisI. Donor heart preservation: current knowledge and the new era of machine perfusion. Int J Mol Sci. 2023;24(23):16693.

[10] GruntzigA. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978;1(8058):263.

[11] OkanoS, ShibaY. Therapeutic potential of pluripotent stem cells for cardiac repair after myocardial infarction. Biol Pharm Bull. 2019;42(4):524-530.

[12] CashmanTJ, Gouon-Evans V, CostaKD. Mesenchymal stem cells for cardiac therapy: practical challenges and potential mechanisms. Stem Cell Rev Rep. 2013;9(3):254-265.

[13] SamsonrajRM, Raghunath M, NurcombeV, HuiJH, van Wijnen AJ, CoolSM. Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem Cells Transl Med. 2017;6(12):2173-2185.

[14] AlonzoM, Anilkumar S, RomanB, TasnimN, JoddarB. 3D bioprinting of cardiac tissue and cardiac stem cell therapy. Transl Res. 2019;211:64-83.

[15] ZhangY, Mignone J, MacLellanWR. Cardiac regeneration and stem cells. Physiol Rev. 2015;95(4):1189-1204.

[16] CsöbönyeiováM, PolákŠ, Danišovič L. Perspectives of induced pluripotent stem cells for cardiovascular system regeneration. Exp Biol Med. 2015;240(5):549-556.

[17] OhnukiM, Takahashi K. Present and future challenges of induced pluripotent stem cells. Philos Trans R Soc, B. 2015;370(1680):20140367.

[18] ZhuD, ChengK. Cardiac cell therapy for heart repair: should the cells be left out? Cells. 2021;10(3):641.

[19] GalloMP, Ramella R, AlloattiG, et al. Limited plasticity of mesenchymal stem cells cocultured with adult cardiomyocytes. J Cell Biochem. 2007;100(1):86-99.

[20] NguyenPK, Neofytou E, RheeJW, WuJC. Potential strategies to address the major clinical barriers facing stem cell regenerative therapy for cardiovascular disease: a review. JAMA Cardiol. 2016;1(8):953-962.

[21] KeshtkarS, Azarpira N, GhahremaniMH. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther. 2018;9(1):63.

[22] WangRM, Christman KL. Decellularized myocardial matrix hydrogels: in basic research and preclinical studies. Adv Drug Deliv Rev. 2016;96:77-82.

[23] McMahanS, TaylorA, CopelandKM, Pan Z, LiaoJ, HongY. Current advances in biodegradable synthetic polymer based cardiac patches. J Biomed Mater Res A. 2020;108(4):972-983.

[24] CristalliniC, Vaccari G, BarbaniN, et al. Cardioprotection of PLGA/gelatine cardiac patches functionalised with adenosine in a large animal model of ischaemia and reperfusion injury: a feasibility study. J Tissue Eng Regener Med. 2019;13(7):1253-1264.

[25] BoroumandS, HaeriA, NazeriN, Rabbani S. Review insights in cardiac tissue engineering: cells, scaffolds, and pharmacological agents. Iran J Pharm Res. 2021;20(4):467-496.

[26] ChaudhuriR, Ramachandran M, MoharilP, HarumalaniM, Jaiswal AK. Biomaterials and cells for cardiac tissue engineering: current choices. Mater Sci Eng C. 2017;79:950-957.

[27] WangZ, LeeSJ, ChengH-J, Yoo JJ, AtalaA. 3D bioprinted functional and contractile cardiac tissue constructs. Acta Biomater. 2018;70:48-56.

[28] OngCS, Fukunishi T, ZhangH, et al. Biomaterial-free three-dimensional bioprinting of cardiac tissue using human induced pluripotent stem cell derived cardiomyocytes. Sci Rep. 2017;7:4566.

[29] YeungE, Fukunishi T, BaiY, et al. Cardiac regeneration using human-induced pluripotent stem cell-derived biomaterial-free 3D-bioprinted cardiac patch in vivo. J Tissue Eng Regener Med. 2019;13(11):2031-2039.

[30] DasKK, TiwariRM, ShankarO, Maiti P, DubeyAK. Tissue-engineered vascular grafts for cardiovascular disease management: current strategies, challenges, and future perspectives. MedComm—Biomater Appl. 2024;3(3):e88.

[31] LiuJ, SongQ, YinW, et al. Bioactive scaffolds for tissue engineering: a review of decellularized extracellular matrix applications and innovations. Exploration. 2024:20230078.

[32] XuC, LiuZ, ChenX, et al. Bone tissue engineering scaffold materials: fundamentals, advances, and challenges. Chin Chem Lett. 2023:109197.

[33] ZhaoW, ZhuJ, HangJ, Zeng W. Biomaterials to promote vascularization in tissue engineering organs and ischemic fibrotic diseases. MedComm—Biomater Appl. 2022;1(1):e16.

[34] BalasubramanianP, Prabhakaran MP, KaiD, RamakrishnaS. Human cardiomyocyte interaction with electrospun fibrinogen/gelatin nanofibers for myocardial regeneration. J Biomater Sci Polym Ed. 2013;24(14):1660-1675.

[35] BearziC, Gargioli C, BaciD, et al. PlGF-MMP9-engineered iPS cells supported on a PEG-fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium. Cell Death Dis. 2014;5:1053.

[36] RavichandranR, Venugopal JR, SundarrajanS, MukherjeeS, Sridhar R, RamakrishnaS. Expression of cardiac proteins in neonatal cardiomyocytes on PGS/fibrinogen core/shell substrate for cardiac tissue engineering. Int J Cardiol. 2013;167(4):1461-1468.

[37] HosoyamaK, Ahumada M, McTiernanCD, et al. Nanoengineered electroconductive collagen-based cardiac patch for infarcted myocardium repair. ACS Appl Mater Interfaces. 2018;10(51):44668-44677.

[38] Rezvani GhomiE, Nourbakhsh N, Akbari KenariM, ZareM, Ramakrishna S. Collagen-based biomaterials for biomedical applications. J Biomed Mater Res Part B Appl Biomater. 2021;109(12):1986-1999.

[39] AcostaBB, Advincula RCC, Grande-TovarCD. Chitosan-based scaffolds for the treatment of myocardial infarction: a systematic review. Molecules. 2023;28(4):1920.

[40] KeX, LiM, WangX, et al. An injectable chitosan/dextran/β -glycerophosphate hydrogel as cell delivery carrier for therapy of myocardial infarction. Carbohydr Polymers. 2020;229:115516.

[41] WangX, WangL, WuQ, et al. Chitosan/calcium silicate cardiac patch stimulates cardiomyocyte activity and myocardial performance after infarction by synergistic effect of bioactive ions and aligned nanostructure. ACS Appl Mater Interfaces. 2019;11(1):1449-1468.

[42] FurlaniF, Campodoni E, SangiorgiN, et al. Electroconductive scaffolds based on gelatin and PEDOT:PSS for cardiac regeneration. Int J Biiol Macromol. 2023;224:266-280.

[43] CattelanG, Guerrero Gerbolés A, ForestiR, et al. Alginate formulations: current developments in the race for hydrogel-based cardiac regeneration. Front Bioeng Biotechnol. 2020;8.

[44] Karimi HajishorehN, Baheiraei N, NaderiN, SalehniaM. Reduced graphene oxide facilitates biocompatibility of alginate for cardiac repair. J Bioact Compat Polym. 2020;35(4-5):363-377.

[45] SondermeijerHP, Witkowski P, SekiT, van der LaarseA, ItescuS, HardyMA. RGDfK-peptide modified alginate scaffold for cell transplantation and cardiac neovascularization. Tissue Eng Part A. 2018;24(9-10):740-751.

[46] BonafèF, GovoniM, GiordanoE, Caldarera CM, GuarnieriC, MuscariC. Hyaluronan and cardiac regeneration. J Biomed Sci. 2014;21:100.

[47] DerkusB. Human cardiomyocyte-derived exosomes induce cardiac gene expressions in mesenchymal stromal cells within 3D hyaluronic acid hydrogels and in dose-dependent manner. J Mater Sci: Mater Med. 2021;32(1):2.

[48] LiH, BaoM, NieY. Extracellular matrix-based biomaterials for cardiac regeneration and repair. Heart Fail Rev. 2021;26(5):1231-1248.

[49] NairRS, SobhanPK, ShenoySJ, et al. A porcine cholecystic extracellular matrix conductive scaffold for cardiac tissue repair. J Biomed Mater Res Part B Appl Biomater. 2022;110(9):2039-2049.

[50] Esmaeili PourfarhangiK, Mashayekhan S, AslSG, HajebrahimiZ. Construction of scaffolds composed of acellular cardiac extracellular matrix for myocardial tissue engineering. Biologicals. 2018;53:10-18.

[51] Pascual-GilS, Simón-Yarza T, GarbayoE, PrósperF, Blanco-Prieto MJ. Cytokine-loaded PLGA and PEG-PLGA microparticles showed similar heart regeneration in a rat myocardial infarction model. Int J Pharm. 2017;523(2):531-533.

[52] RazzaqueMA, XuX, HanM, BadamiA, AkhterSA. Inhibition of postinfarction ventricular remodeling by high molecular weight polyethylene glycol. J Surg Res. 2018;232:171-178.

[53] JonderianA, Maalouf R. Formulation and in vitro interaction of Rhodamine-B loaded PLGA nanoparticles with cardiac myocytes. Front Pharmacol. 2016;7:458.

[54] ZhangC, ChengY, LiuD, et al. Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats. J Nanobiotechnol. 2019;17(1):18.

[55] ArifZU, KhalidMY, NorooziR, Sadeghianmaryan A, JalalvandM, HossainM. Recent advances in 3D-printed polylactide and polycaprolactone-based biomaterials for tissue engineering applications. Int J Biiol Macromol. 2022;218:930-968.

[56] NagiahN, El Khoury R, OthmanMH, et al. Development and characterization of furfuryl-gelatin electrospun scaffolds for cardiac tissue engineering. ACS Omega. 2022;7(16):13894-13905.

[57] SpearmanBS, HodgeAJ, PorterJL, et al. Conductive interpenetrating networks of polypyrrole and polycaprolactone encourage electrophysiological development of cardiac cells. Acta Biomater. 2015;28:109-120.

[58] JahnP, KargerRK, Soso KhalafS, et al. Engineering of cardiac microtissues by microfluidic cell encapsulation in thermoshrinking non-crosslinked PNIPAAm gels. Biofabrication. 2022;14(3):035017.

[59] LiZ, GuoX, MatsushitaS, Guan J. Differentiation of cardiosphere-derived cells into a mature cardiac lineage using biodegradable poly(N-isopropylacrylamide) hydrogels. Biomaterials. 2011;32(12):3220-3232.

[60] RenS, JiangX, LiZ, et al. Physical properties of poly(N-isopropylacrylamide) hydrogel promote its effects on cardiac protection after myocardial infarction. J Int Med Res. 2012;40(6):2167-2182.

[61] ShiM, BaiL, XuM, et al. Micropatterned conductive elastomer patch based on poly (glycerol sebacate)-graphene for cardiac tissue repair. Biofabrication. 2022;14(3):035001.

[62] KharazihaM, Nikkhah M, ShinSR, et al. PGS:Gelatin nanofibrous scaffolds with tunable mechanical and structural properties for engineering cardiac tissues. Biomaterials. 2013;34(27):6355-6366.

[63] BertuoliPT, Ordoño J, ArmelinE, et al. Electrospun conducting and biocompatible uniaxial and core-shell fibers having poly(lactic acid), poly(ethylene glycol), and polyaniline for cardiac tissue engineering. ACS Omega. 2019;4(2):3660-3672.

[64] SuQ, ShiW, HuangX, Yin S, YangX, LuX. Recent advances of nanobody applications in diagnosis and detection. MedComm—Biomater Appl. 2023;2(3):e54.

[65] TanL, ShiY, XuY, et al. Ultrathin PdAu nanowires with high alloying degree for the direct oxidation of methane to C1 oxygenates. Chin J Chem. 2024.

[66] KhanS, HasanA, AttarF, et al. Gold nanoparticle-based platforms for diagnosis and treatment of myocardial infarction. ACS Biomater Sci Eng. 2020;6(12):6460-6477.

[67] BaeiP, Jalili-Firoozinezhad S, Rajabi-ZeletiS, Tafazzoli-ShadpourM, Baharvand H, AghdamiN. Electrically conductive gold nanoparticle-chitosan thermosensitive hydrogels for cardiac tissue engineering. Mater Sci Eng C. 2016;63:131-141.

[68] AustinLA, MackeyMA, DreadenEC, El-Sayed MA. The optical, photothermal, and facile surface chemical properties of gold and silver nanoparticles in biodiagnostics, therapy, and drug delivery. Arch Toxicol. 2014;88(7):1391-1417.

[69] JeyarajM, Sathishkumar G, SivanandhanG, et al. Biogenic silver nanoparticles for cancer treatment: an experimental report. Colloids Surf B. 2013;106:86-92.

[70] ZhangY, FanW, WangK, Wei H, ZhangR, WuY. Novel preparation of Au nanoparticles loaded laponite nanoparticles/ECM injectable hydrogel on cardiac differentiation of resident cardiac stem cells to cardiomyocytes. J Photochem Photobiol, B. 2019;192:49-54.

[71] LeeC, HuangHS, WangYY, et al. Stretchable, adhesive, and biocompatible hydrogel based on iron-dopamine complexes. Polymers. 2023;15(22):4378.

[72] WuT, CuiC, HuangY, et al. Coadministration of an adhesive conductive hydrogel patch and an injectable hydrogel to treat myocardial infarction. ACS Appl Mater Interfaces. 2020;12(2):2039-2048.

[73] Brett RungeM, Dadsetan M, BaltrusaitisJ, et al. The development of electrically conductive polycaprolactone fumarate-polypyrrole composite materials for nerve regeneration. Biomaterials. 2010;31(23):5916-5926.

[74] ZouY, QinJ, HuangZ, Yin G, PuX, HeD. Fabrication of aligned conducting PPy-PLLA fiber films and their electrically controlled guidance and orientation for neurites. ACS Appl Mater Interfaces. 2016;8(20):12576-12582.

[75] LiZ, ZhouY, LiT, ZhangJ, TianH. Stimuli-responsive hydrogels: fabrication and biomedical applications. VIEW. 2022;3(2):20200112.

[76] SavchenkoA, KireevD, YinRT, Efimov IR, MolokanovaE. Graphene-based cardiac sensors and actuators. Front Bioeng Biotechnol. 2023;11:1168667.

[77] LiuY, YuD, ZengC, Miao Z, DaiL. Biocompatible graphene oxide-based glucose biosensors. Langmuir. 2010;26(9):6158-6160.

[78] RaslanA, Saenz Del Burgo L, CirizaJ, PedrazJL. Graphene oxide and reduced graphene oxide-based scaffolds in regenerative medicine. Int J Pharm. 2020;580:119226.

[79] HasanA, WatersR, RoulaB, et al. Engineered biomaterials to enhance stem cell-based cardiac tissue engineering and therapy. Macromol Biosci. 2016;16(7):958-977.

[80] Roacho-PerezJA, Garza-Trevino EN, Moncada-SaucedoNK, et al. Artificial scaffolds in cardiac tissue engineering. Life-Basel. 2022;12(8):1117.

[81] HasanA, Khattab A, IslamMA, et al. Injectable hydrogels for cardiac tissue repair after myocardial infarction. Adv Sci. 2015;2(11):1500122.

[82] WanX, ZhaoY, LiZ, LiL. Emerging polymeric electrospun fibers: from structural diversity to application in flexible bioelectronics and tissue engineering. Exploration. 2022;2(1):20210029.

[83] DattolaE, Parrotta EI, ScaliseS, et al. Development of 3D PVA scaffolds for cardiac tissue engineering and cell screening applications. RSC Adv. 2019;9(8):4246-4257.

[84] GregoryDA, TaylorCS, FrickerATR, et al. Polyhydroxyalkanoates and their advances for biomedical applications. Trends Mol Med. 2022;28(4):331-342.

[85] BirlaRK. A methodological nine-step process to bioengineer heart muscle tissue. Tissue Cell. 2020;67:101425.

[86] BatE, ZhangZ, FeijenJ, Grijpma DW, PootAA. Biodegradable elastomers for biomedical applications and regenerative medicine. Regener Med. 2014;9(3):385-398.

[87] ZhangF, KingMW. Biodegradable polymers as the pivotal player in the design of tissue engineering scaffolds. Adv Healthcare Mater. 2020;9(13):e1901358.

[88] AhmadiP, NazeriN, DerakhshanMA, GhanbariH. Preparation and characterization of polyurethane/chitosan/CNT nanofibrous scaffold for cardiac tissue engineering. Int J Biiol Macromol. 2021;180:590-598.

[89] PesceM, DudaGN, ForteG, et al. Cardiac fibroblasts and mechanosensation in heart development, health and disease. Nat Rev Cardiol. 2023;20(5):309-324.

[90] WeiX, ZhuangL, LiH, et al. Advances in multidimensional cardiac biosensing technologies: from electrophysiology to mechanical motion and contractile force. Small. 2020;16(50):e2005828.

[91] ZarrintajP, Bakhshandeh B, SaebMR, et al. Oligoaniline-based conductive biomaterials for tissue engineering. Acta Biomater. 2018;72:16-34.

[92] KaiserNJ, KantRJ, MinorAJ, Coulombe KLK. Optimizing blended collagen-fibrin hydrogels for cardiac tissue engineering with human iPSC-derived cardiomyocytes. ACS Biomater Sci Eng. 2019;5(2):887-899.

[93] JinM, ShiJ, ZhuW, YaoH, WangDA. Polysaccharide-based biomaterials in tissue engineering: a review. Tissue Eng Part B Rev. 2021;27(6):604-626.

[94] BaghersadS, Sathish Kumar A, KipperMJ, PopatK, WangZ. Recent advances in tissue-engineered cardiac scaffolds—The progress and gap in mimicking native myocardium mechanical behaviors. J Funct Biomater. 2023;14(5):269.

[95] HwangGT, ByunM, JeongCK, Lee KJ. Flexible piezoelectric thin-film energy harvesters and nanosensors for biomedical applications. Adv Healthcare Mater. 2015;4(5):646-658.

[96] AsaroGA, Solazzo M, SukuM, et al. MXene functionalized collagen biomaterials for cardiac tissue engineering driving iPSC-derived cardiomyocyte maturation. npj 2D Mater Appl. 2023;7(1):44.

[97] BezuidenhoutD, Williams DF, ZillaP. Polymeric heart valves for surgical implantation, catheter-based technologies and heart assist devices. Biomaterials. 2015;36:6-25.

[98] ZhaoY, ZhangZ, PanZ, LiuY. Advanced bioactive nanomaterials for biomedical applications. Exploration. 2021;1(3):20210089.

[99] RazaviM, Primavera R, VykuntaA, ThakorAS. Silicone-based bioscaffolds for cellular therapies. Mater Sci Eng C. 2021;119:111615.

[100] CongY, FuJ. Hydrogel-Tissue interface interactions for implantable flexible bioelectronics. Langmuir. 2022;38(38):11503-11513.

[101] CristalliniC, Cibrario Rocchietti E, AccomassoL, et al. The effect of bioartificial constructs that mimic myocardial structure and biomechanical properties on stem cell commitment towards cardiac lineage. Biomaterials. 2014;35(1):92-104.

[102] WangC, XuY, XiaJ, et al. Multi-scale hierarchical scaffolds with aligned micro-fibers for promoting cell alignment. Biomed Mater. 2021;16(4):045047.

[103] ChenS, HsiehM-H, LiS-H, et al. A conductive cell-delivery construct as a bioengineered patch that can improve electrical propagation and synchronize cardiomyocyte contraction for heart repair. J Controlled Release. 2020;320:73-82.

[104] GaoP-H, ChenC, WangX-Y. Heteroatom-doped graphene nanoribbons: precision synthesis and emerging properties. Chin J Chem. 2024.

[105] R. AminD, SinkE, NarayanSP, Abdel-Hafiz M, MestroniL, PeñaB. Nanomaterials for cardiac tissue engineering. Molecules. 2020;25(21):5189.

[106] HuT, WuY, ZhaoX, et al. Micropatterned, electroactive, and biodegradable poly(glycerol sebacate)-aniline trimer elastomer for cardiac tissue engineering. Chem Eng J. 2019;366:208-222.

[107] RuanJL, Tulloch NL, RazumovaMV, et al. Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue. Circulation. 2016;134(20):1557-1567.

[108] Di FrancescoD, Pigliafreddo A, CasarellaS, Di NunnoL, Mantovani D, BoccafoschiF. Biological materials for tissue-engineered vascular grafts: overview of recent advancements. Biomolecules. 2023;13(9):1389.

[109] TariqU, GuptaM, PathakS, Patil R, DohareA, MisraSK. Role of biomaterials in cardiac repair and regeneration: therapeutic intervention for myocardial infarction. ACS Biomater Sci Eng. 2022;8(8):3271-3298.

[110] ZhangX, LiuY, ZhangG, et al. Synergic silencing of costimulatory molecules prevents cardiac allograft rejection. J Transl Med. 2014;12:142.

[111] BestC, TaraS, WietM, et al. Deconstructing the tissue engineered vascular graft: evaluating scaffold pre-wetting, conditioned media incubation, and determining the optimal mononuclear cell source. ACS Biomater Sci Eng. 2017;3(9):1972-1979.

[112] OngCS, ZhouX, HuangCY, Fukunishi T, ZhangH, HibinoN. Tissue engineered vascular grafts: current state of the field. Expert Rev Med Devices. 2017;14(5):383-392.

[113] DrewsJD, Miyachi H, ShinokaT. Tissue-engineered vascular grafts for congenital cardiac disease: clinical experience and current status. Trends Cardiovascul Med. 2017;27(8):521-531.

[114] LiM, WuH, YuanY, Hu B, GuN. Recent fabrications and applications of cardiac patch in myocardial infarction treatment. VIEW. 2022;3(2):20200153.

[115] ChangT, LiuC, YangH, et al. Fibrin-based cardiac patch containing neuregulin-1 for heart repair after myocardial infarction. Colloids Surf B. 2022;220:112936.

[116] NoorN, Shapira A, EdriR, GalI, Wertheim L, DvirT. 3D printing of personalized thick and perfusable cardiac patches and hearts. Adv Sci. 2019;6(11):1900344.

[117] DvirT, TimkoBP, BrighamMD, et al. Nanowired three-dimensional cardiac patches. Nat Nanotechnol. 2011;6(11):720-725.

[118] BejleriD, Streeter BW, NachlasALY, et al. A bioprinted cardiac patch composed of cardiac-specific extracellular matrix and progenitor cells for heart repair. Adv Healthcare Mater. 2018;7(23):e1800672.

[119] RoselliniE, Lazzeri L, MaltintiS, VanniF, Barbani N, CasconeMG. Development and characterization of a suturable biomimetic patch for cardiac applications. J Mater Sci: Mater Med. 2019;30(11):126.

[120] SunX, NunesSS. Overview of hydrogel-based strategies for application in cardiac tissue regeneration. Biomed Mater. 2015;10(3):034005.

[121] KimSH, HongH, AjiteruO, et al. 3D bioprinted silk fibroin hydrogels for tissue engineering. Nat Protoc. 2021;16(12):5484-5532.

[122] KimY, Zharkinbekov Z, RaziyevaK, et al. Chitosan-based biomaterials for tissue regeneration. Pharmaceutics. 2023;15(3):807.

[123] HeS, ZhangZ, LuoR, JiangQ, YangL, Wang Y. Advances in injectable hydrogel strategies for heart failure treatment. Adv Healthcare Mater. 2023;12(19):e2300029.

[124] WuY, WangL, GuoB, MaPX. Interwoven aligned conductive nanofiber yarn/hydrogel composite scaffolds for engineered 3D cardiac anisotropy. ACS Nano. 2017;11(6):5646-5659.

[125] PeñaB, Laughter M, JettS, et al. Injectable hydrogels for cardiac tissue engineering. Macromol Biosci. 2018;18(6):e1800079.

[126] XiaoD, ZhangY, WangR, et al. Emodin alleviates cardiac fibrosis by suppressing activation of cardiac fibroblasts via upregulating metastasis associated protein 3. Acta Pharm Sin B. 2019;9(4):724-733.

[127] EfraimY, SarigH, Cohen AnavyN, et al. Biohybrid cardiac ECM-based hydrogels improve long term cardiac function post myocardial infarction. Acta Biomater. 2017;50:220-233.

[128] SaludasL, Pascual-Gil S, PrósperF, GarbayoE, Blanco-Prieto M. Hydrogel based approaches for cardiac tissue engineering. Int J Pharm. 2017;523(2):454-475.

[129] PennaC, Perrelli MG, KaramJP, et al. Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival. J Cell Mol Med. 2013;17(1):192-204.

[130] MusilliC, KaramJP, PaccosiS, et al. Pharmacologically active microcarriers for endothelial progenitor cell support and survival. Eur J Pharmaceut Biopharmaceut. 2012;81(3):609-616.

[131] Arias-AranaA, Palomino-Marcelo L, Gakiya-TeruyaM, Areche-VargasP, Ramamurthi A, Rodriguez-ReyesJC. Nanoparticles as carriers in medical applications: a review focusing on the preparation and use of nanoparticles in tissue regeneration. Nano Biomed Eng. 2022;14(1).

[132] HamedSH, AzoozEA, Al-MullaEAJ. Nanoparticles-assisted wound healing: a review. Nano Biomed Eng. 2023;15(4):425-435.

[133] LiS, LiF, WangY, et al. Multiple delivery strategies of nanocarriers for myocardial ischemia-reperfusion injury: current strategies and future prospective. Drug Delivery. 2024;31(1):2298514.

[134] WangZ, JinA, YangZ, Huang W. Advanced nitric oxide generating nanomedicine for therapeutic applications. ACS Nano. 2023;17(10):8935-8965.

[135] ZhouQL, ChenZY, WangYX, Yang F, LinY, LiaoYY. Ultrasound-mediated local drug and gene delivery using nanocarriers. BioMed Res Int. 2014;2014:963891.

[136] Masoudi AsilS, Guerrero ED, BugariniG, et al. Theranostic applications of multifunctional carbon nanomaterials. VIEW. 2023;4(2):20220056.

[137] SahooS, KariyaT, IshikawaK. Targeted delivery of therapeutic agents to the heart. Nat Rev Cardiol. 2021;18(6):389-399.

[138] DavidsonSM, Andreadou I, BarileL, et al. Circulating blood cells and extracellular vesicles in acute cardioprotection. Cardiovasc Res. 2019;115(7):1156-1166.

[139] LassenTR, JustJ, HjortbakMV, et al. Cardioprotection by remote ischemic conditioning is transferable by plasma and mediated by extracellular vesicles. Basic Res Cardiol. 2021;116(1):16.

[140] DingS, KimYJ, HuangKY, Um D, JungY, KongH. Delivery-mediated exosomal therapeutics in ischemia-reperfusion injury: advances, mechanisms, and future directions. Nano Converg. 2024;11(1):18.

[141] AlfìE, ThairiC, FemminòS, et al. Extracellular vesicles (EVs) in ischemic conditioning and angiogenesis: focus on endothelial derived EVs. Vascul Pharmacol. 2021;140:106873.

[142] D’AscenzoF, Femminò S, RaveraF, et al. Extracellular vesicles from patients with acute coronary syndrome impact on ischemia-reperfusion injury. Pharmacol Res. 2021;170:105715.

[143] FangZ, ZhangX, HuangH, Wu J. Exosome based miRNA delivery strategy for disease treatment. Chin Chem Lett. 2022;33(4):1693-1704.

[144] WangL, WuY, HuT, GuoB, MaPX. Electrospun conductive nanofibrous scaffolds for engineering cardiac tissue and 3D bioactuators. Acta Biomater. 2017;59:68-81.

[145] XueJ, WuT, DaiY, XiaY. Electrospinning and electrospun nanofibers: methods, materials, and applications. Chem Rev. 2019;119(8):5298-5415.

[146] MeiL, WangY, TongA, Guo G. Facile electrospinning of an efficient drug delivery system. Expert Opin Drug Deliv. 2016;13(5):741-753.

[147] WangY, LiG, YangL, Luo R, GuoG. Development of innovative biomaterials and devices for the treatment of cardiovascular diseases. Adv Mater. 2022;34(46):e2201971.

[148] HasanA, Ragaert K, SwieszkowskiW, et al. Biomechanical properties of native and tissue engineered heart valve constructs. J Biomech. 2014;47(9):1949-1963.

[149] ReisLA, ChiuLLY, FericN, Fu L, RadisicM. Biomaterials in myocardial tissue engineering. J Tissue Eng Regener Med. 2016;10(1):11-28.

[150] CuiH, MiaoS, EsworthyT, et al. 3D bioprinting for cardiovascular regeneration and pharmacology. Adv Drug Deliv Rev. 2018;132:252-269.

[151] SackKL, DaviesNH, GuccioneJM, Franz T. Personalised computational cardiology: patient-specific modelling in cardiac mechanics and biomaterial injection therapies for myocardial infarction. Heart Fail Rev. 2016;21(6):815-826.

[152] LeeM, KimMC, LeeJY. Nanomaterial-based electrically conductive hydrogels for cardiac tissue repair. Int J Nanomedicine. 2022;17:6181-6200.

[153] DaiY, QiaoK, LiD, et al. Plant-derived biomaterials and their potential in cardiac tissue repair. Adv Healthcare Mater. 2023;12(20):e2202827.

[154] ZhangYS, ArneriA, BersiniS, et al. Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip. Biomaterials. 2016;110:45-59.

[155] YangY, ZengW, HuangP, Zeng X, MeiL. Smart materials for drug delivery and cancer therapy. VIEW. 2021;2(2):20200042.

[156] HuC, YangL, WangY. Recent advances in smart-responsive hydrogels for tissue repairing. MedComm—Biomater Appl. 2022;1(2):e23.

[157] El-NablawayM, RashedF, TaherES, et al. Prospectives and challenges of nano-tailored biomaterials-assisted biological molecules delivery for tissue engineering purposes. Life Sci. 2024;349:122671.

[158] ShiH, HuangZ, XuT, SunA, GeJ. New diagnostic and therapeutic strategies for myocardial infarction via nanomaterials. EBioMedicine. 2022;78:103968.

[159] WangH, GuoY, HuY, et al. Ultrasound-controlled nano oxygen carriers enhancing cell viability in 3D GelMA hydrogel for the treatment of myocardial infarction. Int J Biiol Macromol. 2023;244:125139.

[160] BayarsaikhanD, Bayarsaikhan G, LeeJ, LeeB. A study on the protective effect of sRAGE-MSCs in a rodent reperfusion model of myocardial infarction. Int J Mol Sci. 2022;23(24):15630.

[161] QuaziS. Artificial intelligence and machine learning in precision and genomic medicine. Med Oncol. 2022;39(8):120.

[162] NagarajanVD, LeeSL, RobertusJL, Nienaber CA, TrayanovaNA, ErnstS. Artificial intelligence in the diagnosis and management of arrhythmias. Eur Heart J. 2021;42(38):3904-3916.

[163] ZhuX, LiY, GuN. Application of artificial intelligence in the exploration and optimization of biomedical nanomaterials. Nano Biomed Eng. 2023;15(3).

[164] TrayanovaNA, Popescu DM, ShadeJK. Machine learning in arrhythmia and electrophysiology. Circ Res. 2021;128(4):544-566.

[165] AromiwuraAA, SettleT, UmerM, et al. Artificial intelligence in cardiac computed tomography. Prog Cardiovasc Dis. 2023;81:54-77.

[166] ElvasLB, NunesM, FerreiraJC, Dias MS, RosárioLB. AI-Driven decision support for early detection of cardiac events: unveiling patterns and predicting myocardial ischemia. J Pers Med. 2023;13(9):1421.

[167] NagarajanN, YappEKY, LeNQK, Kamaraj B, Al-SubaieAM, YehHY. Application of computational biology and artificial intelligence technologies in cancer precision drug discovery. BioMed Res Int. 2019;2019:8427042.

[168] GuptaNS, KumarP. Perspective of artificial intelligence in healthcare data management: a journey towards precision medicine. Comput Biol Med. 2023;162:107051.

RIGHTS & PERMISSIONS

2024 The Author(s). MedComm - Biomaterials and Applications published by John Wiley & Sons Australia, Ltd on behalf of Sichuan International Medical Exchange & Promotion Association (SCIMEA).